// App-Quantinova.ai

THU0384 : IMPACT OF IXEKIZUMAB ON WORK PRODUCTIVITY IN NON-RADIOGRAPHIC AXIAL SPONDYLOARTHRITIS PATIENTS: RESULTS FROM THE COAST-X TRIAL AT 52 WEEKS

Researchers

Presenter

  • A. Deodhar

Principal Investigators

  • P. J. Mease

  • L. S. Gensler

  • P. Rahman

  • V. Navarro-Compn

  • H. Marzo-Ortega

  • T. Hunter

  • D. Sandoval

  • A. Kronbergs

  • B. Zhu

  • A. Leung

  • V. Strand

Medical Centers

  • Oregon Health & Science University, Portland, United States of America

  • Swedish Medical Center/Providence St Joseph Health, and University of Washington, Seattle, WA

  • UCSF Dept of Medicine , San Francisco, United States of America

  • Memorial University of Newfoundland, St. John's, NF, Canada

  • University Hospital La Paz, Madrid, Spain

  • University of Leeds, West Yorkshire, United Kingdom

  • Eli Lilly and Company, Indianapolis, United States of America

  • Syneos Health, Morrisville, NC, United States of America

  • Stanford University Medical Center, Stanford, California, United States

Locations

  • United States

  • Canada

  • Spain

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • Musculoskeletal

Disease

  • Non-radiographic axial spondyloarthritis

  • Axial spondyloarthritis

Biomarkers

  • N/A

Drug/Treatment

  • LY2439821

Outcome

  • N/A

Study Design

  • Randomized

  • Placebo Control

  • Double Blind/Blinded

  • Open Label

  • Multicenteric

  • Controlled

  • Parallel Group

Phase

  • III

Study Id's

  • NCT02757352

Sponsors

  • Abbvie

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved